BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 32098697)

  • 1. Next generation sequencing of cervical high grade dysplasia and invasive squamous cell carcinoma: A case study.
    Vormittag-Nocito E; Groth JV; Mohapatra G
    Pathol Res Pract; 2020 Apr; 216(4):152863. PubMed ID: 32098697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
    Lee SY; Chae DK; Lee SH; Lim Y; An J; Chae CH; Kim BC; Bhak J; Bolser D; Cho DH
    BMC Cancer; 2020 Jul; 20(1):694. PubMed ID: 32718341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
    Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
    Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of PIK3CA and MDM2 SNP309 with Cervical Squamous Cell Carcinoma in a Philippine Population.
    Tantengco OAG; Nakura Y; Yoshimura M; Llamas-Clark EF; Yanagihara I
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2103-2107. PubMed ID: 31350972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
    Bhat S; Kabekkodu SP; Varghese VK; Chakrabarty S; Mallya SP; Rotti H; Pandey D; Kushtagi P; Satyamoorthy K
    Tumour Biol; 2017 Mar; 39(3):1010428317694573. PubMed ID: 28351298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of oncogenic mutations in cervical carcinoma using method High Resolution Melting (HRM).
    Wayhelova M; Mikulasova A; Smetana J; Vallova V; Blazkova D; Filkova H; Moukova L; Kuglik P
    Neoplasma; 2016; 63(5):779-88. PubMed ID: 27468883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Analysis in Anal and Cervical Cancer: Exploratory Findings About Radioresistance in the ProfiLER Database.
    Rowinski E; Magne N; Bouleftour W; Moreno-Acosta P; DE LA Fourchadiere C; Ray-Coquard I; Wang Q; Blay JY; Tredan O
    Cancer Genomics Proteomics; 2021; 18(4):515-520. PubMed ID: 34183384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Genomic Landscape in Cervical Cancer by Next Generation Sequencing.
    Qiu L; Feng H; Yu H; Li M; You Y; Zhu S; Yang W; Jiang H; Wu X
    Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
    Kashofer K; Regauer S; Reich O; Petru E; Winter E
    Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer.
    Jiang W; He T; Liu S; Zheng Y; Xiang L; Pei X; Wang Z; Yang H
    J Hematol Oncol; 2018 Dec; 11(1):139. PubMed ID: 30547809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
    Lin W; Feng M; Chen G; Zhou Z; Li J; Ye Y
    Oncol Rep; 2017 Mar; 37(3):1477-1486. PubMed ID: 28098890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma.
    Pochylski T; Kwaśniewska A
    Eur J Obstet Gynecol Reprod Biol; 2003 Nov; 111(1):68-73. PubMed ID: 14557015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
    Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
    Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
    Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism.
    Shiota H; Elya JE; Alekseyenko AA; Chou PM; Gorman SA; Barbash O; Becht K; Danga K; Kuroda MI; Nardi V; French CA
    Mol Cancer Res; 2018 Dec; 16(12):1826-1833. PubMed ID: 30139738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis.
    Lea JS; Coleman R; Kurien A; Schorge JO; Miller DS; Minna JD; Muller CY
    Am J Obstet Gynecol; 2004 Mar; 190(3):674-9. PubMed ID: 15041998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERBB2 mutation: A promising target in non-squamous cervical cancer.
    Xiang L; Jiang W; Ye S; He T; Pei X; Li J; Chan DW; Ngan HYS; Li F; Tao P; Shen X; Zhou X; Wu X; Yang G; Yang H
    Gynecol Oncol; 2018 Feb; 148(2):311-316. PubMed ID: 29279289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
    Liu Y; Lu Z; Xu R; Ke Y
    Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
    Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
    Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.